Aspectos Clínicos y Epidemiológicos del VIH y Condiciones Asociadas

Merchante, N; Aldamiz-Echevarria, T; Garcia-Alvarez, M; Rivero-Juarez, A; Macias, J; Miralles, P; Jimenez-Sousa, MA; Mancebo, M; Perez-Latorre, L; Pineda-Tenor, D; Berenguer, J; Resino, S; Pineda, JA.

Bacterial translocation and clinical progression of HCV-related cirrhosis in HIV-infected patients

JOURNAL OF VIRAL HEPATITIS. 2018; 25(2): 180-186 Nº de citas: 4 [doi:10.1111/jvh.12769]

Alvaro-Meca, A; Ryan, P; Martinez-Larrull, E; Micheloud, D; Berenguer, J; Resino, S.

Epidemiological trends of deep venous thrombosis in HIV-infected subjects (1997-2013): A nationwide population-based study in Spain

European Journal of Internal Medicine. 2018; 48: 69-74 Nº de citas: 5 [doi:10.1016/j.ejim.2017.10.012]

Berenguer, J; Jarrin, I; Perez-Latorre, L; Hontanon, V; Vivancos, MJ; Navarro, J; Tellez, MJ; Guardiola, JM; Iribarren, JA; Rivero-Juarez, A; Marquez, M; Artero, A; Morano, L; Santos, I; Moreno, J; Farinas, MC; Galindo, MJ; Hernando, MA; Montero, M; Cifuentes, C; Domingo, P; Sanz, J; Domingez, L; Ferrero, OL; De la Fuente, B; Rodriguez, C; Reus, S; Hernandez-Quero, J; Gaspar, G; Perez-Martinez, L; Garcia, C; Force, L; Veloso, S; Losa, JE; Vilaro, J; Bernal, E; Arponen, S; Orti, AJ; Chocarro, A; Teira, R; Alonso, G; Silvarino, R; Vegas, A; Geijo, P; Bisbe, J; Esteban, H; Gonzalez-Garcia, J.

Human Immunodeficiency Virus/Hepatits C Virus Coinfection in Spain: Elimination Is Feasible, but the Burden of Residual Cirrhosis Will Be Significant

Open Forum Infectious Diseases. 2018; 5(1): Nº de citas: 23 [doi:10.1093/ofid/ofx258]

Garcia, M; Gorgolas, M; Cabello, A; Estrada, V; Ligos, JM; Fernandez-Guerrero, M; Barros, C; Lopez-Bernaldo, JC; De la Hera, FJ; Montoya, M; Benito, JM; Rallon, N.

Peripheral T follicular helper Cells Make a Difference in HIV Reservoir Size between Elite Controllers and Patients on Successful cART

Scientific Reports. 2017; 7: Nº de citas: 24 [doi:10.1038/s41598-017-17057-y]

Guardo, AC; Gomez, CE; Diaz-Brito, V; Pich, J; Arnaiz, JA; Perdiguero, B; Garcia-Arriaza, J; Gonzalez, N; Sorzano, COS; Jimenez, L; Jimenez, JL; Munoz-Fernandez, MA; Gatell, JM; Alcam, J; Esteban, M; de Quiros, JCLB; Garcia, F; Plana, M; RISVAC02boost Study.

Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization

PLoS One. 2017; 12(10): Nº de citas: 17 [doi:10.1371/journal.pone.0186602]

Medrano, LM; Berenguer, J; Jimenez-Sousa, MA; Aldamiz-Echevarria, T; Tejerina, F; Diez, C; Vigon, L; Fernandez-Rodriguez, A; Resino, S.

ADAR1 polymorphisms are related to severity of liver fibrosis in HIV/HCV-coinfected patients

Scientific Reports. 2017; 7: Nº de citas: 10 [doi:10.1038/s41598-017-12885-4]

Guillen, SM; Garcia, JEL; Berenguer, JB; Sesmero, JMM; Gomis, SC; Graefehain, R; Sanchez-Cambronero, DL; Garcia, FJP.

Cost-utility analysis of the fixed-dose combination of dolutegravir/abacavir/lamivudine as initial treatment of HIV plus patients in Spain

FARMACIA HOSPITALARIA. 2017; 41(5): 601-610

Berenguer, J; Rodriguez-Castellano, E; Carrero, A; Von Wichmann, MA; Montero, M; Galindo, MJ; Mallolas, J; Crespo, M; Ellez, MJT; Quereda, C; Sanz, J; Barros, C; Tural, C; Santos, I; Pulido, F; Guardiola, JM; Rubio, R; Ortega, E; Montes, ML; Jusdado, JJ; Gaspar, G; Esteban, H; Bellon, JEM; Gonzalez-Garcia, J.

Eradication of Hepatitis C Virus and Non-Liver-Related Non-Acquired Immune Deficiency Syndrome-Related Events in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection

HEPATOLOGY. 2017; 66(2): 344-356 Nº de citas: 52 [doi:10.1002/hep.29071]

Alvaro-Meca, A; Berenguer, J; Diaz, A; Micheloud, D; Aldamiz-Echevarria, T; Fanciulli, C; Resino, S.

Stroke in HIV-infected individuals with and without HCV coinfection in Spain in the combination antiretroviral therapy era

PLoS One. 2017; 12(6): Nº de citas: 14 [doi:10.1371/journal.pone.0179493]

Montes, ML; Olveira, A; Ahumada, A; Aldamiz, T; Garcia-Samaniego, J; Clemente, A; Berenguer, J; Gonzalez-Garcia, J; Martin-Carbonero, L.

Similar effectiveness of direct-acting antiviral against hepatitis C virus in patients with and without HIV infection

AIDS. 2017; 31(9): 1253-1260 Nº de citas: 36 [doi:10.1097/QAD.0000000000001465]

Rosado-Sanchez, I; Jarrin, I; Pozo-Balado, MM; de Pablo-Bernal, RS; Herrero-Fernandez, I; Alvarez-Rios, AI; Rodriguez-Gallego, E; Genebat, M; Vera, M; Berenguer, J; Martin, ML; Bernal, E; Vidal, F; Blanco, J; Leal, M; Pacheco, YM.

Higher levels of IL-6, CD4 turnover and Treg frequency are already present before cART in HIV-infected subjects with later low CD4 recovery

ANTIVIRAL RESEARCH. 2017; 142: 76-82 Nº de citas: 21 [doi:10.1016/j.antiviral.2017.03.015]

Moreno, S; Antela, A; Garcia, F; del Amo, J; Boix, V; Coll, P; Fortuny, C; Sirvent, JLG; Gutierrez, F; Iribarren, JA; Llibre, JM; de Quiros, JCLB; Losa, JE; Lozano, A; Meulbroek, M; Olalla, J; Pujol, F; Pulido, F; Casal, MC; Garcia, JG; Aldeguer, JL; Molina, JAP; Palter, DP; Roman, AR; Grp Redactor GESIDA SEIMC.

Executive summary: Pre-exposure prophylaxis for prevention of HIV infection in adults in Spain: July 2016

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2017; 35(6): 377-383 Nº de citas: 9 [doi:10.1016/j.eimc.2016.11.016]

Branas, F; Jimenez, Z; Sanchez-Conde, M; Dronda, F; De Quiros, JCLB; Perez-Elias, MJ; Miralles, P; Ramirez, M; Moreno, A; Berenguer, J; Moreno, S.

Frailty and physical function in older HIV-infected adults

AGE AND AGEING. 2017; 46(3): 522-526 Nº de citas: 59 [doi:10.1093/ageing/afx013]

Perez-Lago, L; Herranz, M; Navarro, Y; Serrano, MJR; Miralles, P; Bouza, E; Garcia-De-Viedma, D.

Clonal Complexity in Mycobacterium tuberculosis Can Hamper Diagnostic Procedures

JOURNAL OF CLINICAL MICROBIOLOGY. 2017; 55(5): 1388-1395 Nº de citas: 2 [doi:10.1128/JCM.00149-17]

Sulkowski, MS; Fessel, WJ; Lazzarin, A; Berenguer, J; Zakharova, N; Cheinquer, H; Cote, P; Dieterich, D; Gadano, A; Matthews, G; Molina, JM; Moreno, C; Pineda, JA; Pulido, F; Rivero, A; Rockstroh, J; Hernandez, D; McPhee, F; Eley, T; Liu, ZH; Mendez, P; Hughes, E; Noviello, S; Ackerman, P.

Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study

Hepatology International. 2017; 11(2): 188-198 Nº de citas: 2 [doi:10.1007/s12072-017-9788-z]

Garcia-Alvarez, M; Berenguer, J; Jimenez-Sousa, MA; Pineda-Tenor, D; Aldamiz-Echevarria, T; Tejerina, F; Diez, C; Vazquez-Moron, S; Resino, S.

Mx1, OAS1 and OAS2 polymorphisms are associated with the severity of liver disease in HIV/HCV-coinfected patients: A cross-sectional study

Scientific Reports. 2017; 7: Nº de citas: 25 [doi:10.1038/srep41516]

Karpov, I; Vassilenko, A; Skrahina, A; Klimuk, D; Skrahin, A; Kondratenko, O; Zalutskaya, A; Bondarenko, V; Mitsura, V; Kozorez, E; Tumash, O; Suetnov, O; Paduto, D; Iljina, V; Kummik, T; Bolokadze, N; Mshvidobadze, K; Lanchava, N; Goginashvili, L; Mikiashvili, L; Bablishvili, N; Rozentale, B; Zeltina, I; Janushkevich, I; Caplinskiene, I; Caplinskas, S; Kancauskiene, Z; Podlasin, R; Wiercinska-Drapalo, A; Thompson, M; Kozlowska, J; Grezesczuk, A; Bura, M; Knysz, B; Inglot, M; Garlicki, A; Loster, J; Duiculescu, D; Tetradov, S; Rakhmanova, A; Panteleeva, O; Yakovlev, A; Kozlov, A; Tyukalova, A; Vlasova, Y; Panteleev, A; Trofimova, T; Borodulina, E; Vdoushkina, E; Borodulina, E; Kyselyova, G; Obel, N; Thorsteinsson, K; Payen, MC; Kabeya, K; Necsoi, C; Dabis, F; Bruyand, M; Morlat, P; Dupont, A; Gerard, Y; Bonnal, F; Ceccaldi, J; De Witte, S; Monlun, E; Lataste, P; Chossat, I; Sagette, M; Rickenbach, M; Elzi, L; Battegay, M; Furrer, H; Sculier, D; Calmy, A; Cavassini, M; Bruno, A; Bernasconi, E; Hoffmann, M; Vernazza, P; Fehr, J; Weber, R; Miller, RF; Vora, N; Cooke, G; Mullaney, S; Wilkins, E; George, V; Collini, P; Dockrell, D; Post, F; Campbell, L; Brum, R; Mabonga, E; Saigal, P; Kegg, S; Ainsworth, J; Waters, A; Dhar, J; Mashonganyika, L; Girardi, E; Rianda, A; Galati, V; Pinnetti, C; Tommasi, C; Lapadula, G; Di Biagio, A; Parisini, A; Carbonara, S; Angarano, G; Purgatorio, M; Matteelli, A; Apostoli, A; Miro, JM; Manzardo, C; Ligero, C; Gonzalez, J; Martinez-Martinez, JA; Sanchez, F; Knobel, H; Salvado, M; Lopez-Colomes, JL; Martinez-Lacasa, X; Cuchi, E; Falcoo, V; Curran, A; Tortola, MT; Ocana, I; Vidal, R; Sambeat, MA; Pomar, V; Coll, P; Pozamczer, D; Saumoy, M; Alcaide, F; Cayla, J; Moreno, A; Millet, JP; Orcau, A; Fina, L; Romero, A; Roldan, LL; Iribarren, JA; Ibarguren, M; Moreno, S; Gonzalez, A; Miralles, P; Aldamiz-Echevarria, T; Losso, M; Toibaro, J; Gambardella, L; Toibaro, J; Macias, LM; Warley, E; Tavella, S; Messina, OG; Gear, O; Laplume, H; Marson, C; Contarelia, J; Michaan, M; Scapellato, P; Alessandro, DD; Bartoletti, B; Palmero, D; Elias, C; Cortes, C; Crabtree, B; Gomez, JLM; Villanueva, JA; Hernandez, LAG; Badial, F; Furrer, H; Girardi, E; Bruyand, M; Cayla, JA; Losso, M; Lundgren, JD; Panteleev, A; Miller, RF; Miro, JM; Obel, N; Duiculescu, D; Post, FA; Skrahin, A; Toibaro, J; Schultze, A; Mocroft, A; Efsen, AMW; Mansfeld, M; Aagaard, B; Nielsen, BR; Fisher, AH; Larsen, JF; Raben, D; Podlekareva, DN; Kirk, O; Podlekareva, DN; Schultze, A; Panteleev, A; Skrahina, AM; Miro, JM; Rakhmanova, A; Furrer, H; Losso, MH; Toibaro, J; Vassilenko, A; Girardi, E; Lundgren, JD.

One-year mortality of HIV-positive patients treated for rifampicin-and isoniazid-susceptible tuberculosis in Eastern Europe, Western Europe, and Latin America

AIDS. 2017; 31(3): 375-384 Nº de citas: 10 [doi:10.1097/QAD.0000000000001333]

Wang, Q; De Luca, A; Smith, C; Zangerle, R; Sambatakou, H; Bonnet, F; Smit, C; Schommers, P; Thornton, A; Berenguer, J; Peters, L; Spagnuolo, V; Ammassari, A; Antinori, A; Roldan, EQ; Mussini, C; Miro, JM; Konopnicki, D; Fehr, J; Campbell, MA; Termote, M; Bucher, HC.

Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients

ANNALS OF INTERNAL MEDICINE. 2017; 166(1): 9 Nº de citas: 44 [doi:10.7326/M16-0240]